Browsing by Author "Tsimourtou, Vana"

Now showing items 1-3 of 3

    • Article  

      Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment 

      Rigopoulou, Eirini I.; Gyftaki, Sofia; Arvaniti, Pinelopi; Tsimourtou, Vana; Koukoulis, George K.; Hadjigeorgiou, Georgios; Dalekos, George N. (2019)
      BACKGROUND: Development of autoimmune hepatitis (AIH) has been sporadically reported in patients with multiple sclerosis (MS) either concurrently or after treatment with immunomodulatory drugs, including interferon-beta ...
    • Article  

      Regulatory B and T lymphocytes in multiple sclerosis: friends or foes? 

      Vasileiadis, Georgios K.; Dardiotis, Efthymios; Mavropoulos, Athanasios; Tsouris, Zisis; Tsimourtou, Vana; Bogdanos, Dimitrios P.; Sakkas, Lazaros I.; Hadjigeorgiou, Georgios M. (2018)
      Current clinical experience with immunomodulatory agents and monoclonal antibodies in principle has established the benefit of depleting lymphocytic populations in relapsing–remitting multiple sclerosis (RRMS). B and T ...
    • Article  

      Replication study of GWAS risk loci in Greek multiple sclerosis patients 

      Hadjigeorgiou, Georgios M.; Kountra, Persia-Maria; Koutsis, Georgios; Tsimourtou, Vana; Siokas, Vasileios; Dardioti, Maria; Rikos, Dimitrios; Marogianni, Chrysoula; Aloizou, Athina-Maria; Karadima, Georgia; Ralli, Styliani; Grigoriadis, Nikolaos; Bogdanos, Dimitrios; Panas, Marios; Dardiotis, Efthimios (2019)
      To validate in an ethnically homogeneous Greek multiple sclerosis (MS) cohort, genetic risk factors for the disease, identified through a number of previous multi-ethnic genome-wide association studies (GWAS).